Gates Foundation Invests $40 Million in Immunotherapy Collaboration – BioPharm International
The Times |
Gates Foundation Invests $40 Million in Immunotherapy Collaboration
BioPharm International Gates Foundation Invests $40 Million in Immunotherapy Collaboration. The collaboration with Immunocore, a T cell receptor company, aims to discover and develop immunotherapy molecules to treat infectious diseases. Sep 19, 2017. By BioPharm … Gates Foundation invests $40 mln in UK immunotherapy company Gates foundation invests in British immunotherapy specialist … Goalkeepers – The Stories Behind the Data – The Global Goals |
